Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.

Di Biase L.

J Am Heart Assoc. 2016 Feb 18;5(2). pii: e002776. doi: 10.1161/JAHA.115.002776. Review. No abstract available.

2.

Warfarin dosage adjustment strategy in Chinese population.

Yu Z, Ding YL, Lu F, Miao LY, Shen ZY, Ye WX.

Int J Clin Exp Med. 2015 Jun 15;8(6):9904-10. eCollection 2015.

3.
4.

Systemic thrombolysis: cure for prosthetic mitral valve thrombosis in the comorbid, non-surgical candidate.

Beckord B, Berkowitz R, Espinoza C, Anand N.

BMJ Case Rep. 2014 May 30;2014. pii: bcr2013203071. doi: 10.1136/bcr-2013-203071.

5.

Patterns and determinants of cardiovascular drug utilization in coronary care unit patients of a tertiary care hospital.

George J, Devi P, Kamath DY, Anthony N, Kunnoor NS, Sanil SS.

J Cardiovasc Dis Res. 2013 Dec;4(4):214-21. doi: 10.1016/j.jcdr.2013.12.001. Epub 2014 Feb 6.

6.

Prosthetic heart valve obstruction: thrombolysis or surgical treatment?

Bonou M, Lampropoulos K, Barbetseas J.

Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):122-7. doi: 10.1177/2048872612451169.

7.

Estimation of plasma levels of warfarin and 7-hydroxy warfarin by high performance liquid chromatography in patients receiving warfarin therapy.

Krishna Kumar D, Gopal Shewade D, Parasuraman S, Rajan S, Balachander J, Sai Chandran BV, Adithan C.

J Young Pharm. 2013 Mar;5(1):13-7. doi: 10.1016/j.jyp.2013.02.001. Epub 2013 Mar 16.

8.

Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort.

Di Tullio MR, Jin Z, Russo C, Elkind MS, Rundek T, Yoshita M, DeCarli C, Wright CB, Homma S, Sacco RL.

J Am Coll Cardiol. 2013 Jul 2;62(1):35-41. doi: 10.1016/j.jacc.2013.03.064. Epub 2013 May 1.

9.

Prosthetic tricuspid valve thrombosis: three case reports and literature review.

Yaminisharif A, Alemzadeh-Ansari MJ, Ahmadi SH.

J Tehran Heart Cent. 2012 Nov;7(4):147-55. Epub 2012 Nov 30.

10.

miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle.

Pérez-Andreu V, Teruel R, Corral J, Roldán V, García-Barberá N, Salloum-Asfar S, Gómez-Lechón MJ, Bourgeois S, Deloukas P, Wadelius M, Vicente V, González-Conejero R, Martínez C.

Mol Med. 2013 Jan 22;18:1466-72. doi: 10.2119/molmed.2012.00062.

11.

Successful treatment of acute lymphoblastic leukemia in a child with trisomy 21 and complex congenital heart disease with mechanical prosthetic valve.

Alvi S, Shereck E, Heran MK, Sandor GG, Rassekh SR.

Case Rep Pediatr. 2012;2012:193093. doi: 10.1155/2012/193093. Epub 2012 Oct 2.

12.

Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals.

Anderson AM, Chane T, Patel M, Chen S, Xue W, Easley KA.

AIDS Patient Care STDS. 2012 Aug;26(8):454-62. doi: 10.1089/apc.2012.0068. Epub 2012 Jun 28.

13.

Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study.

McMinn DJ, Snell KI, Daniel J, Treacy RB, Pynsent PB, Riley RD.

BMJ. 2012 Jun 14;344:e3319. doi: 10.1136/bmj.e3319.

14.

42-year-old man with hemoptysis, dyspnea, and orthopnea.

Liang JJ, Bishu KG, Anavekar NS.

Mayo Clin Proc. 2012 May;87(5):497-500. doi: 10.1016/j.mayocp.2012.02.007. No abstract available.

15.

Lost and found: catastrophic en block embolism of a mechanical prosthetic valve thrombus after thrombolytic therapy.

Panduranga P, Alam F, Ratnam L, Al-Zadjali M, Al-Deeb M.

Sultan Qaboos Univ Med J. 2012 May;12(2):242-4. Epub 2012 Apr 9. No abstract available.

16.

Postoperative anticoagulation in patients with mechanical heart valves following surgical treatment of subdural hematomas.

Amin AG, Ng J, Hsu W, Pradilla G, Raza S, Quinones-Hinojosa A, Lim M.

Neurocrit Care. 2013 Aug;19(1):90-4. doi: 10.1007/s12028-012-9704-2.

17.

Severe mitral annular calcification in rheumatic heart disease: A rare presentation.

Vijayvergiya R, Vaiphei K, Rana SS.

World J Cardiol. 2012 Mar 26;4(3):87-9. doi: 10.4330/wjc.v4.i3.87.

18.

Case study and review: treatment of tricuspid prosthetic valve thrombosis.

Zhang DY, Lozier J, Chang R, Sachdev V, Chen MY, Audibert JL, Horvath KA, Rosing DR.

Int J Cardiol. 2012 Dec 15;162(1):14-9. doi: 10.1016/j.ijcard.2011.09.081. Epub 2011 Oct 14. Review.

19.

Using highly variable warfarin dosing to identify patients at risk for adverse events.

Marrast L, Evans M, Ozonoff A, Henault LE, Rose AJ.

Thromb J. 2011 Oct 10;9:14. doi: 10.1186/1477-9560-9-14.

20.

Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician.

Leiria TL, Lopes RD, Williams JB, Katz JN, Kalil RA, Alexander JH.

J Thromb Thrombolysis. 2011 May;31(4):514-22. doi: 10.1007/s11239-011-0574-9. Review.

Items per page

Supplemental Content

Write to the Help Desk